Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 281,571 |
|
|||||
| News | - | ||||||
| Day High | 2.26 | Low High |
|||||
| Day Low | 2.01 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Immix Biopharma Inc | IMMX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.01 | 0.48% | 2.09 | 14:02:37 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.01 | 2.01 | 2.26 | 2.08 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 801 | 281,571 | $ 2.15 | $ 603,988 | - | 1.55 - 7.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:04:23 | 2 | $ 2.09 | USD |
Immix Biopharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 41.92M | 19.87M | - | 0 | -15.43M | -0.78 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Immix Biopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMMX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.05 | 2.30 | 2.00 | 2.09 | 74,221 | 0.04 | 1.95% |
| 1 Month | 2.35 | 2.68 | 1.7503 | 2.13 | 101,957 | -0.26 | -11.06% |
| 3 Months | 3.05 | 3.3528 | 1.7503 | 2.42 | 123,571 | -0.96 | -31.48% |
| 6 Months | 4.27 | 7.75 | 1.7503 | 4.01 | 248,553 | -2.18 | -51.05% |
| 1 Year | 1.92 | 7.75 | 1.55 | 3.76 | 215,559 | 0.17 | 8.85% |
| 3 Years | 5.00 | 8.6799 | 0.68 | 4.15 | 1,141,946 | -2.91 | -58.20% |
| 5 Years | 5.00 | 8.6799 | 0.68 | 4.15 | 1,141,946 | -2.91 | -58.20% |
Immix Biopharma Description
| Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation. |
